Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…This multidisciplinary group has fought for CF patients' rights and currently has targeted the implementation of personalized and precision medicine for the management of the disease. The relevance of this group becomes even more evident when we consider the value associated with the use of precision and personalized medicine in Brazil [20]. Moreover, it is important to optimize the diagnosis of CF in Brazil and to provide full access to therapy to all patients to avoid the disparities in relation to race and other issues because it is well known that race can compromise the diagnosis and the treatment even when using new modulator strategies [40,[48][49][50][51].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This multidisciplinary group has fought for CF patients' rights and currently has targeted the implementation of personalized and precision medicine for the management of the disease. The relevance of this group becomes even more evident when we consider the value associated with the use of precision and personalized medicine in Brazil [20]. Moreover, it is important to optimize the diagnosis of CF in Brazil and to provide full access to therapy to all patients to avoid the disparities in relation to race and other issues because it is well known that race can compromise the diagnosis and the treatment even when using new modulator strategies [40,[48][49][50][51].…”
Section: Discussionmentioning
confidence: 99%
“…In this context, although there have been advances in CF diagnosis and treatment in the last few decades, morbidity and mortality still present high indices in patients with CF. Importantly, not all patients with CF have proper access to treatment [20], mainly regarding the new medications that modulate the expression of the CFTR protein [5]. For this reason and due to the diversity of CFTR variants associated with racial groups and Brazilian regions, the CF diagnosis and management in Brazil is still a challenge to be overcome, along with other diseases that affect the lungs and are caused by pathogenic variants in other genes (e.g., primary ciliary dyskinesia) [21,22].…”
Section: Introductionmentioning
confidence: 99%